NZ250581A - (all e)-3,7-dimethyl-9-[3,5-dimethyl-2-(nonyloxy)phenyl]-2,4,6,8- nonatetraenoic acid and pharmaceutically acceptable salts and hydrolysable esters; pharmaceutical compositions - Google Patents

(all e)-3,7-dimethyl-9-[3,5-dimethyl-2-(nonyloxy)phenyl]-2,4,6,8- nonatetraenoic acid and pharmaceutically acceptable salts and hydrolysable esters; pharmaceutical compositions

Info

Publication number
NZ250581A
NZ250581A NZ250581A NZ25058193A NZ250581A NZ 250581 A NZ250581 A NZ 250581A NZ 250581 A NZ250581 A NZ 250581A NZ 25058193 A NZ25058193 A NZ 25058193A NZ 250581 A NZ250581 A NZ 250581A
Authority
NZ
New Zealand
Prior art keywords
compound
pharmaceutically acceptable
formula
dimethyl
composition
Prior art date
Application number
NZ250581A
Other languages
English (en)
Inventor
Thomas I Doran
Michael Rosenberger
Stanley Seymour Shapiro
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NZ250581A publication Critical patent/NZ250581A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/734—Ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/225—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
  • Optical Communication System (AREA)
  • Processing Of Meat And Fish (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
NZ250581A 1993-01-06 1993-12-23 (all e)-3,7-dimethyl-9-[3,5-dimethyl-2-(nonyloxy)phenyl]-2,4,6,8- nonatetraenoic acid and pharmaceutically acceptable salts and hydrolysable esters; pharmaceutical compositions NZ250581A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/001,144 US5369126A (en) 1993-01-06 1993-01-06 Nonatetraenoic acid derivative for use in treating acne

Publications (1)

Publication Number Publication Date
NZ250581A true NZ250581A (en) 1995-12-21

Family

ID=21694605

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ250581A NZ250581A (en) 1993-01-06 1993-12-23 (all e)-3,7-dimethyl-9-[3,5-dimethyl-2-(nonyloxy)phenyl]-2,4,6,8- nonatetraenoic acid and pharmaceutically acceptable salts and hydrolysable esters; pharmaceutical compositions

Country Status (24)

Country Link
US (1) US5369126A (2)
EP (1) EP0606614B1 (2)
JP (1) JP2563158B2 (2)
KR (1) KR940018351A (2)
CN (1) CN1098086A (2)
AT (1) ATE150442T1 (2)
AU (1) AU668239B2 (2)
BR (1) BR9400020A (2)
CA (1) CA2110336A1 (2)
CZ (1) CZ2194A3 (2)
DE (1) DE69309029T2 (2)
DK (1) DK0606614T3 (2)
ES (1) ES2099894T3 (2)
FI (1) FI940040A7 (2)
GR (1) GR3023582T3 (2)
HU (1) HUT65945A (2)
IL (1) IL108246A (2)
MX (1) MX9400200A (2)
NO (1) NO180534C (2)
NZ (1) NZ250581A (2)
PL (1) PL301783A1 (2)
TW (1) TW247311B (2)
UY (1) UY23707A1 (2)
ZA (1) ZA939805B (2)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998008089A1 (en) * 1996-08-23 1998-02-26 Arch Development Corporation Identification of activators and inhibitors of sebum formation
US6294188B1 (en) 1998-07-09 2001-09-25 Aviana Biopharm Inc. Methods involving changing the constitutive and stimulated secretions of the local reproductive system of women
US20140014137A1 (en) 2009-09-18 2014-01-16 Ecolab Usa Inc. Treatment of non-trans fats with acidic tetra sodium l-glutamic acid, n, n-diacetic acid (glda)
BR112012006168A2 (pt) * 2009-09-18 2017-08-29 Ecolab Usa Inc Tratamento de manchas de gorduras não trans, ácidos graxos e protetor solar com um agente quelante
US10253281B2 (en) 2012-08-20 2019-04-09 Ecolab Usa Inc. Method of washing textile articles
MX2017009840A (es) 2015-01-29 2017-11-02 Ecolab Usa Inc Composicion y metodo para el tratamiento de manchas en textiles.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4648996A (en) * 1984-07-27 1987-03-10 Hoffmann-La Roche Inc. Phenyl substituted-2,4,6,8-nonatetraenoic acid
ZA854828B (en) * 1984-07-27 1986-03-26 Hoffmann La Roche Phenyl nonatetraenoic acid derivatives

Also Published As

Publication number Publication date
ATE150442T1 (de) 1997-04-15
JP2563158B2 (ja) 1996-12-11
IL108246A0 (en) 1994-04-12
TW247311B (2) 1995-05-11
NO180534B (no) 1997-01-27
NO940034L (2) 1994-07-07
FI940040L (fi) 1994-07-07
DE69309029T2 (de) 1997-10-30
HUT65945A (en) 1994-08-29
EP0606614B1 (en) 1997-03-19
AU5243293A (en) 1994-07-14
ES2099894T3 (es) 1997-06-01
IL108246A (en) 1997-06-10
NO180534C (no) 1997-05-07
EP0606614A1 (en) 1994-07-20
DE69309029D1 (de) 1997-04-24
BR9400020A (pt) 1994-08-16
DK0606614T3 (da) 1997-09-22
JPH06234698A (ja) 1994-08-23
CZ2194A3 (en) 1994-07-13
ZA939805B (en) 1994-07-06
KR940018351A (ko) 1994-08-16
PL301783A1 (en) 1994-07-11
CA2110336A1 (en) 1994-07-07
NO940034D0 (no) 1994-01-05
CN1098086A (zh) 1995-02-01
GR3023582T3 (en) 1997-08-29
HU9400001D0 (en) 1994-05-30
FI940040A7 (fi) 1994-07-07
UY23707A1 (es) 1994-06-05
MX9400200A (es) 1994-07-29
US5369126A (en) 1994-11-29
FI940040A0 (fi) 1994-01-05
AU668239B2 (en) 1996-04-26

Similar Documents

Publication Publication Date Title
CA2087251C (en) Pharmaceutical compositions
US9750750B2 (en) Compositions and methods for stimulating hair growth
JP3950046B2 (ja) レゾルシノール誘導体
US20050058614A1 (en) Methods for the treatment of gray hair using cyclopentane(ene) heptan(en)oic acid amides
US4588750A (en) Therapeutic compositions for reducing sebum secretion
EP0606614B1 (en) Nonatetraenoic acid derivative
CA2016985C (en) Dehydrocholecalciferol derivatives
JP2003531113A (ja) 皮脂腺障害のためのコレステロールエステルとワックスエステルの合成の二重阻害剤
JPH10511653A (ja) カルシトリオール代謝の阻害剤としてのベンゾイミダゾール類
US20260034104A1 (en) Process for preparing a potent thiazole compound, pharmaceutical formulation and uses thereof
AU2019260644B2 (en) Process for preparing a potent thiazole compound, pharmaceutical formulation and uses thereof
US20100172957A1 (en) Eflucimibe medicaments for preventing/treating a disease due to sebaceous gland dysfunction in humans or animals
JPH03197455A (ja) β―ヨノン―フエニルヒドラゾン
HK1231769A1 (en) Compositions and methods for stimulating hair growth
AU2017228614A1 (en) Compositions and methods for stimulating hair growth